These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9675482)

  • 21. Ketoconazole in the treatment of visceral leishmaniasis (kala-azar).
    Ahasan HA; Rafiqueuddin AK; Azhar MA; Chowdhury MA
    Trop Doct; 1996 Oct; 26(4):197-8. PubMed ID: 8937249
    [No Abstract]   [Full Text] [Related]  

  • 22. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.
    Araujo FG; Lin T; Remington JS
    J Infect Dis; 1993 Feb; 167(2):494-7. PubMed ID: 8421189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of a combination of paromomycin and miltefosine for two vs. three courses in patients with post-kala-azar dermal leishmaniasis: an observational pilot study.
    Pandey K; Pal B; Das VNR; Murti K; Lal CS; Verma N; Bimal S; Ali V; Verma RB; Topno RK; Siddiqi NA; Das P
    Br J Dermatol; 2017 Aug; 177(2):557-559. PubMed ID: 27781268
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral miltefosine in the treatment of kala-azar.
    Mohan A; Seth S
    Natl Med J India; 2000; 13(4):202-3. PubMed ID: 11002688
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinico-epidemiological study of kala-azar in the south of Madrid].
    de la Serna FJ; Salto E; Valdés D; Vos Saus R
    Rev Sanid Hig Publica (Madr); 1987; 61(7-8):783-98. PubMed ID: 3438697
    [No Abstract]   [Full Text] [Related]  

  • 27. [Kala-azar in childhood].
    Ballin A; Theodor R; Boichis H; Rotem Y; Altman G
    Harefuah; 1980 Jun; 98(11-12):501-3. PubMed ID: 7203192
    [No Abstract]   [Full Text] [Related]  

  • 28. Post kala-azar ocular leishmaniasis.
    el Hassan AM; Khalil EA; el Sheikh EA; Zijlstra EE; Osman A; Ibrahim ME
    Trans R Soc Trop Med Hyg; 1998; 92(2):177-9. PubMed ID: 9764325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atovaquone: a review.
    Haile LG; Flaherty JF
    Ann Pharmacother; 1993 Dec; 27(12):1488-94. PubMed ID: 8305784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure.
    Colakoglu M; Yaylali GF; Colakoglu NY; Yilmaz M
    Scand J Infect Dis; 2006; 38(2):152-4. PubMed ID: 16449014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined effect of atovaquone and pyrrolidine dithiocarbamate in the treatment of acute murine toxoplasmosis.
    Djurković-Djaković O; Nikolić A; Bobić B; Klun I
    Chemotherapy; 2004 Jun; 50(3):155-6. PubMed ID: 15272229
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies of the anemia of kala-azar in 68 childhood cases. Specific antiparasitic chemotherapy is the most effective treatment.
    Hiçsönmez G; Ozsoylu S
    Clin Pediatr (Phila); 1977 Aug; 16(8):733-6. PubMed ID: 872484
    [No Abstract]   [Full Text] [Related]  

  • 33. Combination therapy in Kala-azar.
    Singh NK; Jha TK; Singh IJ; Jha S
    J Assoc Physicians India; 1995 May; 43(5):319-20. PubMed ID: 9081958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of leishmaniasis with miltefosine: 2008 status.
    Berman JJ
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1209-16. PubMed ID: 18721114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of babesiosis.
    Weiss LM; Wittner M; Tanowitz HB
    N Engl J Med; 2001 Mar; 344(10):773. PubMed ID: 11236789
    [No Abstract]   [Full Text] [Related]  

  • 36. Kala-azar in Afghanistan.
    Singh M; Arya LS; Aram GN; Fazal MI; Qureshi MA; Goel RG
    J Trop Med Hyg; 1982 Oct; 85(5):201-4. PubMed ID: 7176002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
    Karki P; Koirala S; Parija SC; Hansdak SG; Das ML
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):154-8. PubMed ID: 9740292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar.
    Thakur CP; Sinha PK
    J Trop Med Hyg; 1989 Dec; 92(6):383-5. PubMed ID: 2607570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kala-azar--progress against a neglected disease.
    Murray HW
    N Engl J Med; 2002 Nov; 347(22):1793-4. PubMed ID: 12456856
    [No Abstract]   [Full Text] [Related]  

  • 40. Blindness following visceral leishmaniasis: a neglected post-kala-azar complication.
    Khalil EA; Musa AM; Younis BM; Elfaki ME; Zijlstra EE; Elhassan AM
    Trop Doct; 2011 Jul; 41(3):139-40. PubMed ID: 21676981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.